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There are many transcriptional regulators found in pathogenic Staphylococcus 
aureus. Many of these regulators are essential for the organism’s ability to switch from 
commensal form to the virulent pathogenic form. One of these main regulators is CodY. 
This regulator has been shown to be responsive to nutrient availability during phases of 
growth. Additionally, we have recently found that MsaB, the only protein coding ORF of 
the msaABCR operon, is a putative co-regulator of capsule along with CodY.  To explore 
these regulator interactions, we produced mutations of codY and msaABCR individually 
and a double mutation of msaABCR/ codY. We have observed that both MsaB and CodY 
bind to the cap promoter region in very close proximity. CodY binds to this region in 
early phases of growth in response to nutrients as a repressor of cap transcription and 
MsaB binds to this region in the later phase of growth as an activator of cap transcription. 
Using a chemically defined medium (CDM), we have shown that the msaABCR operon 
and ultimately MsaB is also likely involved in sensing nutrient availability. In this study, 
we show that the transcriptional regulator, MsaB, interacts with another known DNA 
binding transcriptional regulator, CodY, in S. aureus. These interactions are important in 
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Chapter I: Introduction 
The purpose of this study is to gain more insight on the transcriptional regulation 
of capsule production in Staphylococcus aureus. Because of the increasing inefficacy of 
current microbial treatments, there has been a shift in the field of microbiology to 
examine molecular pathways involved in the expression of virulence factors employed by 
the pathogen during a successful infection. This information will lead to the development 
of more specific treatments that silence expression pathways that make the pathogen 
more virulent. Gyan Sahukhal and Mohamed Elasri (2014) identified a four-gene operon, 
msaABCR, in S. aureus.  The study also specifically defined MsaB, the only protein 
produced by the operon, as a regulator of virulence in S. aureus. Another protein, CodY, 
has been identified as a direct link between virulence and nutrient availability in the 
different phases of growth (Pohl, et. al 2009). We further examined the role of MsaB and 
CodY proteins in the regulation and production of capsule in S. aureus and studied the 
different nutrient conditions surrounding the expression of capsule. 
Justification 
 Since the recent discovery of the protein, MsaB, as a regulator, there has been 
limited published research on the specific actions of MsaB during the expression of 
capsule. This study is unique because it looks closely at the interaction of CodY and 
MsaB at the capsule promoter region in S. aureus. Research in the field has identified that 
nutrients influence the production of capsule in S. aureus, but there has not been any 
direct mechanism of this nutrient dependent regulation identified. We gain more insight 




To examine the regulatory relationship between MsaB and CodY,  singleCodY, 
single mutations of codY and msaABCR as well as a double codY/ msaABCR mutant were 
analyzed to see how the mutations effected capsule expression compared to the wild type 
strain.  E. coli was used as an expression system to express and purify MsaB protein as 
was done in previous work (Batte, et. al., 2016). This protein was used to perform 
binding assays and investigate what nutrient conditions hinder or promote capsule 
production. 
The Chromatin Immunoprecipitation assay was used to determine if and in what 
phase of growth CodY and MsaB bind to the capsule promoter region. ChIP analysis 
involves using an antibody produced specific to the desired protein to bind to the protein-
antigen complex formed in a crosslinked treated total cell lysate (Das et. al, 2004). We 
harvested cells during the different phases of growth and grown under different 
conditions to discover when MsaB and CodY are bound to the capsule promoter region.  
Outcomes 
We hypothesize that both MsaB and CodY bind to the cap promoter region in 
very close proximity in different phases of growth.  We hope to determine if CodY binds 
to this region in early phases of growth as a repressor of cap transcription and if MsaB 
binds to this region in the later phase of growth as an activator of cap transcription.  
Other groups have shown that CodY responds directly to nutrient availability (Pohl et al, 
2009).  Using chemically defined medium or CDM also determined that MsaB is 
involved in sensing nutrients in the cell. 
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As growth continues, and the bacteria start to use up the nutrients in the media, 
CodY loses its affinity to bind the capsule promoter region and then MsaB binds to 
promote the capsule expression. In the nutrient depleted condition, MsaB binds to the cap 
promoter region in earlier phases of growth. By observing the activity of the capsule 
promoter region in the codY mutant and msaABCR mutant more information was 
uncovered on the other pathways the organism employs to produce capsule and persist in 
its’ environment. 
Significance 
Methicillin resistant S. aureus is a priority for disease control due to infections 
being able to quickly escalate to a medical emergency. The rising ineffectiveness of 
current antibiotics creates a crisis in medicine as microbial mutation and contact 
continues to increase. As a result, there is a growing section of research focused on the 
study of the genetic pathways that make S. aureus more virulent. This study looks at how 
the cell’s environment plays a role in the regulation of transcriptional factors. This 
regulation then affects the translation of virulent factors. Capsule is the specific virulence 
factor looked at in this study. The capsule enables the cell to resist phagocytosis by 
immune cells (Voyich et. al, 2005). Encapsulated organisms are found in asymptomatic 
colonization, abscesses and septicemia, which can lead to complex and life threatening 
infections. Outlining the transcriptional factors involved in the genetic pathway of 
capsule production in S. aureus will lead to the development of a new generation of 
antimicrobials. These antimicrobials could be developed to directly target certain 
virulence factors including capsule and lead to hindering the cell’s ability to establish 
  4
infection. The less virulent cell would be more susceptible to antibiotics and the host’s 
immune cells, which could produce better patient outcomes. 
Chapter II: Literature Review 
Staphylococcus aureus is one of the major causes of fatal nosocomial infection in 
hospitals. One of the reasons why this bacterium is so successful at infecting even the 
healthiest of individuals is because it contains a vast collection of virulence factors 
(Cassedevall and Pirfoski, 2001). These virulence factors include phenotypic 
characteristics, such as a polysaccharide capsule, and the bacteria’s ability to resist 
antibiotic treatment. The Centers for Disease Control and Prevention reported the first 
case of vancomycin resistant Staphylococcus aureus in 2002 (Goldrick, 2002). This was 
alarming because vancomycin is used to treat methicillin resistant S. aureus strains as a 
drug of last resort or (DoLR). The increase in the rate of bacterial success in infection and 
colonization of the host creates a crisis in healthcare that calls for a more effective 
treatment and understanding of the transcriptional pathways that lead the production of 
the virulence factors that S. aureus employs during the infection. Not all colonization of 
S. aureus is harmful to the host. In fact, a large percentage of the population is colonized 
by S. aureus and experience no symptoms (Graham et al, 2006). S. aureus colonization 
becomes infectious when the organism switches from commensal to virulent form. An 
understanding of the environmental conditions and genetic pathways that cause this 
bacterium to switch from benign to virulent could be used to develop new types of 




Genetic Regulation of Virulence in S. aureus  
 The accessory gene regulator, agr, and the staphylococcal accessory gene 
regulator, sar, are two important global regulatory pathways for the expression of 
virulence in S. aureus (Dunman, 2001). Agr is responsible for quorum sensing of the cell 
(Queck et. al, 2008). Quorum sensing involves regulating expression of certain genes in 
response to cell-population densities toward the later stages of growth, such as the post-
exponential phase (Queck et. al, 2008). A study done by Chan and Foster (1998) 
identifies the agr locus is also activated by the protein produced by the sar locus, sarA. 
SarA is a regulatory DNA binding protein that can regulate virulence expression through 
the agr locus by binding to the promoter regions, P1 and P2 (Dunman, 2001). SarA is 
also capable of regulating virulence independent of the agr locus (Dunman, 2001). The 
independent method of activating virulence involves direct interaction between SarA and 
the regions of noncoding DNA that regulate the transcription of virulence factors 
(Dunman, 2001). The study identifies SarA as a signal transducer that responds to oxygen 
and carbon dioxide availability in the cell (Dunman, 2001). Sambanthamoory et. al 
(2006) discovered a region of DNA that modifies the production and function of SarA 
and named it msa, modulator of sarA. This study suggests that it is a membrane protein in 
which mutation cause a decreased expression of SarA and virulence. These discoveries 
lead to studies that identified and defined the regulatory mechanisms employed by msa or 
(modulator of sarA). Gyan Sahukhal and Mohamed Elasri (2014) examined a msa 
deletion mutant and found that the deletion had an effect of the genes just upstream of 
msa. This study found that the msa was a part of a four-gene operon, msaABCR, that 
regulates many of virulence factors in S. aureus. The msaABCR operon is made up of 
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msaA, msaB, msaC (previously known as msa), and msaR. msaB is the only region of the 
operon that codes for a 66-amino acid protein named MsaB protein. The study identified 
MsaB as a regulator of several virulence factors, but does not describe how the protein 
interacts with other factors or what causes the cell to employ that pathway of gene 
expression. Further research is needed on the relationship between MsaB, SarA, and agr 
in expression of virulence.  
Capsule 
 The main virulence factor of my interest is the production of a capsule, an 
extracellular polysaccharide covering produced by the cell. The capsule protects the cells 
during harsh environments by helping it to resist desiccation and nutrient loss. Capsule 
serotype 5 and 8 are predominately found in clinical environments (O’Riordian and Lee, 
2004).  The capsule boosts the success of S. aureus in the bloodstream by preventing 
phagocytosis by leukocytes (Karakawa et. al 1998). O’Riordian and Lee (2004) further 
supported this observation with the finding that the two major opsonins, complement and 
antibody, were unable to bind to the encapsulated strains and therefore inhibiting 
leukocytic opsonophagocytosis. Many studies have shown that capsule production is 
highly sensitive to environmental signals. Herbert et. al (1997) showed that capsule 
serotype 5 production is dependent of carbon dioxide availability. Lee et al (1993) 
demonstrated that increased iron levels in growth conditions limited the production of 
capsule serotype 8. Capsule production is maximally expressed during the post 
exponential growth phase in in vitro models (Pöhlmann-Dietze, 2000). Luong et. al 
(2002) showed that the agr locus plays a role in the expression of capsule by quorum-
sensing. Therefore, as the bacteria continue to grow in a set amount of media, the 
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increasing number of organisms start to deplete the nutrients and the density of the 
bacteria increases. These factors put the bacteria under stressful conditions in which 
prompt the production of virulence factors such as the capsule for protection.  
The Role of codY in S. aureus 
 The idea of the cell sensing nutrients and then adapting its phenotype to best fit its 
environment lead to studies on the gene, codY. A study done by Pohl et. al (2009) 
demonstrated the sensitivity of CodY protein to nutrients and its regulation of virulence. 
The study suggests that under conditions of amino acid surplus, CodY represses the 
virulence genes that would help the bacteria live in limited nutrient environments. codY 
null mutants and wild type strains were grown in chemically defined media (CDM) 
containing all three-branched chain amino acids (BCAAs), valine, leucine, and 
isoleucine. Analysis of this data showed that the codY mutants grew more slowly than 
wild type in the CDM. Because codY works as a repressor of virulence, it masks many of 
the virulence factors that would help the bacteria survive in low nutrient environments. 
Majerczyk et al. (2010) identified that CodY was active by the presence of BCAAs. They 
also found that CodY controls the expression of virulence genes through sensing nutrients 
in the cells’ environment. They also noted that CodY represses some genes of the cap 
locus directly and through a agr locus dependent manner. Pohl et. al (2009) found that 
isoleucine specifically has a more dominant effect on CodY compared to the other 
branched chain amino acids (BCAAs). This suggests that genes needed for growth are 
repressed by CodY during heavy isoleucine concentrations, which indicates that 
isoleucine is a major ligand regulating CodY repression of virulence. More research is 
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needed on the interactions on agr, SarA, MsaB, and CodY in relation to the environment 
to completely outline the transcriptional pathway of capsule production in S. aureus. 
Protein Purification and Expression 
Studying the interactions of CodY and MsaB require purified protein samples of 
each. Bornhorst, et. al (2000) detailed an efficient way of producing a large amount of 
desired protein using E. coli as an expression vector. The construction of the plasmid 
involves amplifying the region of DNA that codes for the protein from the organism that 
will be produced. This region is then ligated into a digested plasmid with six amino acid 
histidine tags. The plasmid is then transformed into E. coli and it contains instructions in 
its own genetic material on how to create the protein from the organism. Harvesting the 
protein from the E. coli involves growing and lysing the cells and then separating the 
protein from the cell debris by centrifuging the sample. Centrifuging the lysed cells 
leaves the protein suspended in the media and the large cell fragments spun towards the 
bottom of the container. Next the lysate is run through a nickel resin column. Histidine 
binds to the nickel inside the column as the lysate passes through the resin. In this study, 
buffer containing 10 mM imidazole was used to wash out any undesired proteins that 
may have bound to the nickel column because they contained one or two histidine tags. 
After washing multiple times with the low amount of imidazole, eluting the rest of the 
desired six histidine tagged protein was accomplished by increasing the amount 
imidazole concentration to 250 mM. This model of protein purification can be used in 
many different organismal models. Once the protein is purified, it can be used in different 
binding assays to detect the region of DNA in which the protein associates.  
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Protein DNA Interaction Studies 
 Das et. al (2004) described an assay that observes protein and DNA interactions 
called chromatin immunoprecipitation, (ChIP). ChIP involves extracting the protein and 
DNA complexes from whole cell fragments using an antibody generated from the protein 
of interest. ChIP is a useful method for the study due to it allows to test what phase of 
growth the protein associates or disassociates with the DNA region. This is especially 
important because the expression of many virulence factors such as capsule have been 
shown to be growth-phase dependent (Dunman, et.al, 2001).  
Chapter III: Methodology 
This study uncovers more information about the transcriptional mechanism S. 
aureus utilizes during the different environmental conditions that it encounters, 
specifically focusing on the genetic pathways involving the MsaB and CodY proteins. 
CodY has been shown to be a major repressor of virulence factors in response to nutrient 
availability in the different phases of growth (Pohl et. al, 2009). The protein MsaB has 
been previously identified as a regulator of virulence factors but little is known about this 
expression pathway (Batte, et. al, 2016). To assess the relationship between MsaB and 
CodY in capsule production, we analyzed the capsule expression of a codY mutant, 
msaABCR mutant, and a double msaABCR/codY mutant compared to wild type to test the 
effects these mutants made on growth and regulation of capsule production. Large 
amounts of CodY and MsaB protein were expressed using E. coli as an expression vector. 
The purified protein can then be used to perform binding assay to the capsule promoter 
region and protein interaction studies. 
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Growth Curves in Chemically Defined Medium 
 The mutants were grown with optical density (OD) measured hourly in an 
extended growth curve for at least 12 hours using chemically define media (CDM). 
Similar to the study done by Pohl et.al (2009), the bacteria were grown in plain CDM and 
CDM without branched chain amino acids (BCAAs) valine, isoleucine, leucine. The 
strains, msaABCR mutant, msaABCR complement, and wild type were normalized to an 
OD of 0.05, in CDM and incubated while shaking at 37° Celsius.  The OD was measured 
hourly to observe the growth rate of the msaABCR mutant and complement compared to 
wild type.   
Protein Expression and Purification 
Purified samples of CodY and MsaB protein are needed to study the interactions 
and binding sites of each.  E. coli is an organism commonly used as a protein expression 
vector because it is highly efficient and cost effective (Hannig, 1998). We created a 
plasmid constructs with an antibiotic marker that contains the codY or msaB protein 
coding region with a six-histidine tag and transform the plasmid into E. coli (Charpentier 
et. al, 2004). The cells were grown in one liter of Luria-Bertani broth (LB) at 37° Celsius 
for 5 hours. The cell lysate was created by using a sonicator with amplitude of 30% for 
20 seconds on and 1 minute off repeated seven times. The lysate was centrifuged at 
10,000 G for 20 minutes to remove cell debris. Following the Bornhorst and Falke (2000) 
detailed protocol of purifying the six-histidine tag codY protein using a nickel resin 
column. The lysate was run through a charged nickel resin column twice. The column 
was washed with at least 40 ml of wash buffer containing 10 mM imidazole, verifying 
with a negative Bradford reagent reading of the lysate that all nonspecific proteins were 
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eluted through. Our protein was eluted with the elution buffer that contains 250 mM 
imidazole.  
Chromatin Immunoprecipitation Assay 
Sengupta et. al (2004) detailed the chromatin immunoprecipitation, ChIP, assay is 
used to determine if and in what phase of growth does MsaB and CodY associate with the 
cap promoter region using a whole cell lysate. The codY mutant, msaABCR mutant, and 
wild type were liquid cultured under two conditions (CDM and CDM with no BCAAs) 
and incubating at 37° Celsius. Cells were then collected during the early-, mid-, late-, and 
post-exponential phases of growth. The crosslinking reaction was initiated by treating the 
cells with 1% formaldehyde and 10 nM sodium phosphate. The crosslinking reaction was 
stopped when 3 M glycine was added to the solution. Spinning and washing the cultures 
with an equal volume on 0.1 M phosphate buffer removed excess formaldehyde. The 
cells were pelleted to remove the phosphate buffer and then resuspended in 200 uL of 
immunoprecipitation (IP) buffer. After the cells were bead beaten the cells were spun to 
remove cell debris. The lysate was diluted with 1 ml of IP buffer. The diluted antibody 
was added to 200 uL of clear lysate and incubated at room temperature for 2 hours. The 
mixture was added to Protein-G-coupled magnetic beads and incubated for one hour. A 
magnetic tube holder was used to collect the antigen-antibody-bead complex washed with 
tris buffer saline and ultrapure water. To reverse crosslinks, the beads were resuspended 
in elution buffer an incubated 65 C overnight. Phenol-chloroform extraction method was 
used to extract the DNA. Polymerase chain reaction was then used to amplify the DNA 
with site specific primers. 
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Chapter IV: Results 
Restricted Nutrient Growth Curves 
 The results of the growth curve in CDM and CDM without BCAAs media are 
presented in Figure 1 and Figure 2 respectively. All bacteria strains experienced an 
extended lag phage in both CDM and CDM without BCAAs. There was also a slower 
growth of all strains of the bacteria in either of the CDM medium compared to a rich 
medium, tryptic soy broth (TSB). Additionally, all the strains had an extended lag phase 
initially. However, msaABCR operon mutant showed slightly decreased growth rates and 
patterns as well as a more pronounced extended lag phase compared to wild type and 
complement in whole CDM media. Interestingly, in the CDM without BCAAs the wild 
type and complement has a very long lag phase and seem to grow very slowly. However, 
the msaABCR mutant growth is very similar, in a putative “uncontrolled” manner, in 
CDM without BCAAs compared to whole CDM medium.  Taken together, these results 
suggest that in an unidentified mechanism the msaB and ultimately the msaABCR operon 











Figure 1 Growth curve in CDM with S. aureus strains of wildtype, msaABCR 
mutant, and msaABCR compliment for nine hours 
 
Figure 2 Growth curve in CDM with no BCAAs with S. aureus strains of wildtype, 





Chromatin Immunoprecipitation Assays 
Figure 3 shows results of ChIP analysis of wild type, msaABCR operon mutant, 
and the codY mutant. The codY mutant had visible bands in all phases of growth. This 
means that there is binding of MsaB protein to the capsule promoter region in all phases 
of growth. This differs from wild type in that MsaB only binds to the cap promoter 
region in late- and post-exponential phase of growth. Importantly, these results suggest 
that in an undetermined mechanism that CodY, when present in wild type, is inhibiting 
MsaB binding in early phases of growth. The ChIP analysis in CDM media and CDM 
without BCAAs (nutrient limited conditions) revealed that MsaB binds to the cap 
promoter region in the mid-exponential phases of growth in wild type, independent of 
CodY presence.  Interestingly, in limited nutrient conditions even in conditions when 
CodY is supposed to be bound (whole CDM) MsaB binds independently of CodY shown 
in Figure 4.  This data suggest that MsaB may be sensing nutrient availability itself 
altering its binding ability to its target. However, more work needs to be done to establish 
this putative nutrient sensing mechanism of MsaB. 
 
Figure 3 ChIP analysis in TSB of S. aureus wildtype, msaABCR mutant, ccpE 




Figure 4 ChIP analysis of CDM and CDM with no BCAAs of S. aureus wildtype, 
msaABCR mutant, ccpE mutant, and codY mutant in mid-exponential phase of 
growth 
 
Chapter V: Discussion   
The msaABCR operon plays a role in the growth and regulatory activity or 
virulence genes in nutrient limited conditions. The deletion of msaABCR operon altered 
growth rate compared to wild type and the msaABCR complement, but increased 
regulatory activity (binding) in wild type in the CDM media suggest that certain 
mechanisms that the cell normally employs to survive were limited without the genetic 
information and sensing ability of the msaABCR operon. Thus, the msaABCR operon 
mutant is limited in ability to adapt its phenotype to survive in the stressful environment. 
The similarity of growth in CDM media and CDM media without BCAAs suggest that 
the msaABCR operon mutant is unable to sense and respond to in its environment. 
However, when MsaB or the msaABCR are present in the wild type the organism is able 
to respond properly to changes in nutrient levels.  
Justin Batte (2016) previously showed that the regulation of MsaB and capsule 
production in S. aureus is linked to nutrient availability. MsaB was found to bind to the 
capsule promoter region only in the late phases of growth (Batte, et al, 2016). In the early 
phases of growth MsaB does not bind to the capsule promoter region and there is no 
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capsule production. This coincides with nutrient availability in the cell’s environment. In 
the later phases of growth, there is limited nutrition. This triggers the activation (MsaB 
binding) resulting in capsule production. The result of the ChIP analysis in CDM media 
and CDM without BCAAs shows that MsaB is responding to nutrient availability. CDM 
media is much more minimal in nutrients compared to TSB. The limited environment 
places enough stress on the cell to produce activation of capsule production, as evidenced 
by MsaB binding to the capsule promoter region in the mid-exponential phase of growth. 
Additionally, in rich nutrient conditions in the codY mutant, MsaB bound in all phases of 
growth. Without this global regulator (repressor), the cell does not respond to the 
nutrients in its environment. This suggests that MsaB binds to its target site when the 
known repressor of capsule, CodY, loses its affinity to the site and detaches.  This 
detachment of CodY to its region makes the MsaB binding site accessible for binding.    
More research is needed to identify other transcriptional factors or nutrient stimuli 
involved in the translation of capsule production in S. aureus. In the future, it is important 
to uncover more information about specific nutrients and other signals that stimulate this 
process. We hope to gain more knowledge on how significant the msaABCR operon and 
codY is in sensing nutrients as well as what specific nutrients have a dominant effect on 
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